Back to company

PHARMAORIGIN ApS: Financial statements 2013

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 0 and a net result of DKK -937,714 compared with DKK -149,195 the year before. Equity amounted to DKK -131,994.

Revenue
0 kr.
Gross Profit
0 kr.
Profit/Loss
-937,714 kr.
Equity
-131,994 kr.
Total Assets
5,253,921 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201300-938 t.-132 t.-
2012---149 t.806 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMAORIGIN ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

PHARMAORIGIN ApS appoints new auditorDec 27, 2013

As of December 27, 2013, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of PHARMAORIGIN ApS.

Auditor steps down at PHARMAORIGIN ApSDec 27, 2013

As of December 27, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PHARMAORIGIN ApS.

Kim Arvid Nielsen joins PHARMAORIGIN ApS as adm. dir.Oct 29, 2013

As of October 29, 2013, Kim Arvid Nielsen is registered as adm. dir. of PHARMAORIGIN ApS.

Henrik Lasse Lindblad steps down as adm. dir. of PHARMAORIGIN ApSOct 29, 2013

As of October 29, 2013, Henrik Lasse Lindblad has stepped down as adm. dir. of PHARMAORIGIN ApS.

PHARMAORIGIN ApS: The 2012 annual report is outJun 8, 2013

PHARMAORIGIN ApS has published its annual report for 2012. The net result was DKK -149,195.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.